JUN 20, 2018 7:00 AM EDT

Utilizing Same-Day Sepsis Pathogen ID for Faster Therapy, Enhanced Stewardship, Improved Outcomes

Sponsored by: T2 Biosystems, Inc.
Speaker
  • Associate Professor of Medicine, Infectious Diseases Division and Director, Mycology Program, University of Pittsburgh
    Biography
      Dr. Clancy is the Associate Professor of Medicine in the Infectious Diseases Division and the Director of the Mycology Program at the University of Pittsburgh. Dr. Clancy is widely published and a respected scientific expert on novel diagnostics. He is a leading researcher on antimicrobial resistance in bacteria and fungi and their clinical relevance.

    Abstract

    DATE: June 20, 2018
    TIME: 07:00AM PDT, 10:00AM EDT

    Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes and cost. One of the major hurdles to effective sepsis management is the limitations of conventional diagnostics, which are blood-culture based and take 1 to 5 or more days to identify sepsis-causing pathogens. Blood culture also misses 35-50% of infections altogether on first blood draw and can be greatly affected by the presence of antimicrobials. These delays impact patient outcomes as one hour of delayed treatment increases mortality risk by nearly 8%.

    To advance sepsis care, hospitals are turning to new technology that does not rely on blood culture. This year, six new peer reviewed studies have been published on T2Dx diagnostics, which provide blood culture independent sepsis pathogen ID results in 3 to 5 hours. Due to improved detection, these studies from the U.S. and EU demonstrate that clinicians can achieve faster targeted therapy, better outcomes, enhanced stewardship, and reduced cost of care. The T2Dx Instrument runs the first FDA-cleared tests to identify deadly sepsis-causing pathogens in whole blood: the T2Candida Panel and the now FDA-Cleared T2Bacteria Panel.

    In this webinar you will:

    • Review the latest clinical data on the accuracy and impact of blood culture independent diagnostics
    • Demonstrate the potential for new diagnostics to improve outcomes for patients suspected of sepsis while improving stewardship
    • Understand opportunities and barriers to implementation of blood culture independent diagnostics into routine clinical care and sepsis management protocols

    Show Resources
    You May Also Like
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    JUN 20, 2018 7:00 AM EDT

    Utilizing Same-Day Sepsis Pathogen ID for Faster Therapy, Enhanced Stewardship, Improved Outcomes

    Sponsored by: T2 Biosystems, Inc.

    Specialty

    Microbiology

    Infectious Disease

    Laboratory Testing

    Clinical Diagnostics

    Molecular Diagnostics

    Immunology

    Molecular Biology

    Clinical Chemistry

    Biotechnology

    Biochemistry

    Diagnostics

    Cancer Research

    Cell Biology

    Biomarkers

    Hematology

    Geography

    North America77%

    Asia9%

    Europe9%

    South America2%

    Africa2%

    Registration Source

    Website Visitors60%

    WAVE Newsletter Promotion20%

    Email Promotions18%

    Website Banners1%

    Job Title

    Medical Laboratory Technician18%

    Facility/Department Manager15%

    Lab Management12%

    Clinical Laboratory Scientist11%

    Executive9%

    Medical Doctor/Specialist7%

    Research Scientist6%

    Educator/Faculty5%

    Student4%

    Microbiologist4%

    Pharmacist3%

    Consultant2%

    Scientist2%

    QC/QA2%

    Post Doc1%

    Biologist1%

    Organization

    Hospital33%

    Clinical Laboratory18%

    Academic Institution7%

    Biotech Company5%

    Medical Center5%

    Government4%

    Medical Device Company3%

    Consultant3%

    Research Institute3%

    Medical School2%

    Ambulatory Care2%

    Life Science Company1%

    Distribution/sales1%

    Non-Profit Organization1%

    Other5%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more